Immune-mediated nephritis contributes to disease in systemic lupus erythematosus, Goodpasture syndrome (caused by antibodies specific for glomerular basement membrane [anti-GBM antibodies]), and spontaneous lupus nephritis. Inbred mouse strains differ in susceptibility to anti-GBM antibody–induced and spontaneous lupus nephritis. This study sought to clarify the genetic and molecular factors that may be responsible for enhanced immune-mediated renal disease in these models. When the kidneys of 3 mouse strains sensitive to anti-GBM antibody–induced nephritis were compared with those of 2 control strains using microarray analysis, one-fifth of the underexpressed genes belonged to the kallikrein gene family, which encodes serine esterases. Mouse strains that upregulated renal and urinary kallikreins exhibited less evidence of disease. Antagonizing the kallikrein pathway augmented disease, while agonists dampened the severity of anti-GBM antibody–induced nephritis. In addition, nephritis-sensitive mouse strains had kallikrein haplotypes that were distinct from those of control strains, including several regulatory polymorphisms, some of which were associated with functional consequences. Indeed, increased susceptibility to anti-GBM antibody–induced nephritis and spontaneous lupus nephritis was achieved by breeding mice with a genetic interval harboring the kallikrein genes onto a disease-resistant background. Finally, both human SLE and spontaneous lupus nephritis were found to be associated with kallikrein genes, particularly KLK1 and the KLK3 promoter, when DNA SNPs from independent cohorts of SLE patients and controls were compared. Collectively, these studies suggest that kallikreins are protective disease-associated genes in anti-GBM antibody–induced nephritis and lupus.
Kui Liu, Quan-Zhen Li, Angelica M. Delgado-Vega, Anna-Karin Abelson, Elena Sánchez, Jennifer A. Kelly, Li Li, Yang Liu, Jinchun Zhou, Mei Yan, Qiu Ye, Shenxi Liu, Chun Xie, Xin J. Zhou, Sharon A. Chung, Bernardo Pons-Estel, Torsten Witte, Enrique de Ramón, Sang-Cheol Bae, Nadia Barizzone, Gian Domenico Sebastiani, Joan T. Merrill, Peter K. Gregersen, Gary G. Gilkeson, Robert P. Kimberly, Timothy J. Vyse, Il Kim, Sandra D’Alfonso, Javier Martin, John B. Harley, Lindsey A. Criswell, The Profile Study Group, The Italian Collaborative Group, The German Collaborative Group, The Spanish Collaborative Group, The Argentinian Collaborative Group, The SLEGEN Consortium, Edward K. Wakeland, Marta E. Alarcón-Riquelme, Chandra Mohan
Title and authors | Publication | Year |
---|---|---|
Tissue Kallikrein-1 Suppresses Type I Interferon Responses and Reduces Depressive-Like Behavior in the MRL/lpr Lupus-Prone Mouse Model
Bhoj PS, Nocito C, Togre NS, Winfield M, Lubinsky C, Khan S, Mogadala N, Seliga A, Unterwald EM, Persidsky Y, Sriram U |
International Journal of Molecular Sciences | 2024 |
KLF13 promotes SLE pathogenesis by modifying chromatin accessibility of key proinflammatory cytokine genes.
Wang A, Fairhurst AM, Liu K, Wakeland B, Barnes S, Malladi VS, Viswanathan K, Arana C, Dozmorov I, Singhar A, Du Y, Imam M, Moses A, Chen C, Sunkavalli A, Casco J, Rakheja D, Li QZ, Mohan C, Clayberger C, Wakeland EK, Khan S |
Communications biology | 2024 |
Epitope Spreading: The Underlying Mechanism for Combined Membranous Lupus Nephritis and Anti-GBM Disease?
Sogbein O, Kochar T, Afrouzian M |
Case Reports in Nephrology | 2023 |
Deciphering the Genetic Code of Autoimmune Kidney Diseases
Huang SU, Kulatunge O, O\u2019Sullivan KM |
Genes & development | 2023 |
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
Tang L, Zhong X, Gong H, Tuerxun M, Ma T, Ren J, Xie C, Zheng A, Abudureheman Z, Abudukadeer A, Aini P, Yilamujiang S, Li L |
BMC Pulmonary Medicine | 2022 |
Transcriptome Studies in Lupus Nephritis.
Alarcón-Riquelme ME |
Archivum Immunologiae et Therapiae Experimentalis | 2022 |
Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develop Autoimmunity After Influenza or LCMV Infections
N Szumilas, OB Corneth, CH Lehmann, H Schmitt, S Cunz, JG Cullen, T Chu, A Marosan, A Mócsai, V Benes, D Zehn, D Dudziak, RW Hendriks, L Nitschke |
Frontiers in immunology | 2021 |
Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study
NB Chalvon, P Orquevaux, D Giusti, G Gatouillat, T Tabary, MT Libyh, J Chrusciel, M Drame, G Stockton-Bliard, Z Amoura, L Arnaud, HM Lorenz, G Blaison, B Bonnotte, N Magy-Bertrand, S Revuz, RE Voll, O Hinschberger, A Schwarting, BN Pham, T Martin, JL Pennaforte, A Servettaz |
Frontiers in immunology | 2020 |
Serum proteomics of active tuberculosis patients and contacts reveals unique processes activated during Mycobacterium tuberculosis infection
J Mateos, O Estévez, Á González-Fernández, L Anibarro, Á Pallarés, R Reljic, T Mussá, C Gomes-Maueia, A Nguilichane, JM Gallardo, I Medina, M Carrera |
Scientific Reports | 2020 |
Bradykinin 1 receptor blockade subdues systemic autoimmunity, renal inflammation, and blood pressure in murine lupus nephritis
L Qin, Y Du, H Ding, A Haque, J Hicks, C Pedroza, C Mohan |
Arthritis Research & Therapy | 2019 |
A Variant of the Histone-Binding Protein sNASP Contributes to Mouse Lupus
J Ju, J Xu, Y Zhu, X Fu, L Morel, Z Xu |
Frontiers in immunology | 2019 |
Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection
Kritika Ramani, Chetan Jawale, Akash Verma, Bianca Coleman, Jay Kolls, Partha Biswas |
JCI Insight | 2018 |
Whole Exome Sequencing of Patients from Multicase Families with Systemic Lupus Erythematosus Identifies Multiple Rare Variants
AM Delgado-Vega, M Martínez-Bueno, NY Oparina, DL Herráez, H Kristjansdottir, K Steinsson, SV Kozyrev, ME Alarcón-Riquelme |
Scientific Reports | 2018 |
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review)
M Devetzi, M Goulielmaki, N Khoury, D Spandidos, G Sotiropoulou, I Christodoulou, V Zoumpourlis |
International journal of molecular medicine | 2018 |
IL-17 Receptor Signaling Negatively Regulates the Development of Tubulointerstitial Fibrosis in the Kidney
K Ramani, RJ Tan, D Zhou, BM Coleman, CV Jawale, Y Liu, PS Biswas |
Mediators of Inflammation | 2018 |
Kallikrein–Kinin System Suppresses Type I Interferon Responses: A Novel Pathway of Interferon Regulation
A Seliga, MH Lee, NC Fernandes, V Zuluaga-Ramirez, M Didukh, Y Persidsky, R Potula, S Gallucci, U Sriram |
Frontiers in immunology | 2018 |
IL-17 in Renal Immunity and Autoimmunity
PS Biswas |
Journal of immunology (Baltimore, Md. : 1950) | 2018 |
T cells and autoimmune kidney disease
A Suárez-Fueyo, SJ Bradley, D Klatzmann, GC Tsokos |
Nature Reviews Nephrology | 2017 |
SLE-Associated Defects Promote Altered T Cell Function
JC Crispin, CM Hedrich, A Suárez-Fueyo, D Comte, GC Tsokos |
Critical reviews in immunology | 2017 |
Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection
L Pan, N Wei, H Jia, M Gao, X Chen, R Wei, Q Sun, S Gu, B Du, A Xing, Z Zhang |
Oncotarget | 2017 |
Modelling clinical systemic lupus erythematosus: similarities, differences and success stories
T Celhar, AM Fairhurst |
Rheumatology | 2016 |
Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis
Y Du, T Wu, XJ Zhou, LS Davis, C Mohan |
Inflammation | 2016 |
A systems approach to renal inflammation in SLE
CC Berthier, M Kretzler, A Davidson |
Clinical Immunology | 2016 |
Anti-glomerular basement membrane disease accompanied by systemic lupus erythematosus presenting central nervous system involvement
H Sugawara, H Takizawa, Y Shimamura, N Moniwa, K Hasegawa, Y Ogawa |
CEN Case Reports | 2016 |
Differentiating Glomerular Inflammation from Fibrosis in a Bone Marrow Chimera for Rat Anti-Glomerular Basement Membrane Glomerulonephritis
C Zhou, K Lou, K Tatum, J Funk, J Wu, T Bartkowiak, D Kagan, Y Lou |
American Journal of Nephrology | 2015 |
What is damaging the kidney in lupus nephritis?
A Davidson |
Nature Reviews Rheumatology | 2015 |
Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis
C Mohan, C Putterman |
Nature Reviews Nephrology | 2015 |
Genetics of Lupus Nephritis: Clinical Implications
ME Munroe, JA James |
Seminars in Nephrology | 2015 |
Involvement of Kallikrein-Related Peptidases in Normal and Pathologic Processes
AC Stefanini, BR da Cunha, T Henrique, EH Tajara |
Disease Markers | 2015 |
Kallikrein-kinin in stem cell therapy
J Chao |
World journal of stem cells | 2014 |
Glutathione S-transferase Mu 2-transduced mesenchymal stem cells ameliorated anti-glomerular basement membrane antibody-induced glomerulonephritis by inhibiting oxidation and inflammation
Y Li, M Yan, J Yang, I Raman, Y Du, S Min, X Fang, C Mohan, QZ Li |
Stem Cell Research & Therapy | 2014 |
Forward genetic approaches for elucidation of novel regulators of Lyme arthritis severity
KK Bramwell, C Teuscher, JJ Weis |
Frontiers in Cellular and Infection Microbiology | 2014 |
Delivering Oxidation Resistance-1 (OXR1) to Mouse Kidney by Genetic Modified Mesenchymal Stem Cells Exhibited Enhanced Protection against Nephrotoxic Serum Induced Renal Injury and Lupus Nephritis
CL Yan |
Journal of Stem Cell Research & Therapy | 2014 |
Biomarker Profiling for Lupus Nephritis
Y Li, X Fang, QZ Li |
Genomics Proteomics & Bioinformatics | 2013 |
Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress
Y Li, I Raman, Y Du, M Yan, S Min, J Yang, X Fang, W Li, J Lu, XJ Zhou, C Mohan, QZ Li |
PloS one | 2013 |
Identical twins:one with anti-glomerular basement membrane glomerulonephritis,the other with systemic lupus erythematosus
X Liu, Y Wu, Y Yang, J Wang, Y Tao, P Fu, Z Hu |
BMC Nephrology | 2013 |
Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus
J Bäck, C Lood, AA Bengtsson, KN Ekdahl, B Nilsson |
Arthritis Research & Therapy | 2013 |
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Z Liu, A Davidson |
Nature Medicine | 2012 |
From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine
CC Berthier, M Kretzler, A Davidson |
Journal of Data Mining in Genomics & Proteomics | 2012 |
Treatment targets in systemic lupus erythematosus: biology and clinical perspective
V Marian, JH Anolik |
Arthritis Research & Therapy | 2012 |
Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism
JC Crispín, SA Apostolidis, F Rosetti, M Keszei, N Wang, C Terhorst, TN Mayadas, GC Tsokos |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Effects of IRF5 Lupus Risk Haplotype on Pathways Predicted to Influence B Cell Functions
JM Guthridge, DN Clark, A Templeton, N Dominguez, R Lu, GS Vidal, JA Kelly, KM Kauffman, JB Harley, PM Gaffney, JA James, BD Poole |
Journal of Biomedicine and Biotechnology | 2012 |
Murine Models of Systemic Lupus Erythematosus
D Perry, A Sang, Y Yin, YY Zheng, L Morel |
Journal of Biomedicine and Biotechnology | 2011 |
AP-1 Transcription Factor JunD Confers Protection from Accelerated Nephrotoxic Nephritis and Control Podocyte-Specific Vegfa Expression
HT Cook, R Tarzi, Z D'Souza, G Laurent, WC Lin, TJ Aitman, F Mechta-Grigoriou, J Behmoaras |
The American Journal of Pathology | 2011 |
Cutting edge: Calcium/Calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis
K Ichinose, T Rauen, YT Juang, K Kis-Toth, M Mizui, T Koga, GC Tsokos |
Journal of immunology (Baltimore, Md. : 1950) | 2011 |
Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells
D Arasappan, W Tong, P Mummaneni, H Fang, S Amur |
BMC Medicine | 2011 |
Novel Therapeutic Approaches to Lupus Glomerulonephritis: Translating Animal Models to Clinical Practice
H Bagavant, K Kalantarinia, Y Scindia, U Deshmukh |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2011 |
The United States to Africa lupus prevalence gradient revisited
G Gilkeson, J James, D Kamen, T Knackstedt, D Maggi, A Meyer, N Ruth |
Lupus | 2011 |
Glomerular Antibodies in Lupus Nephritis
C Hanrotel-Saliou, I Segalen, YL Meur, P Youinou, Y Renaudineau |
Clinical Reviews in Allergy & Immunology | 2010 |
Pathogenesis of human systemic lupus erythematosus: recent advances
JC Crispín, SN Liossis, K Kis-Toth, LA Lieberman, VC Kyttaris, YT Juang, GC Tsokos |
Trends in Molecular Medicine | 2010 |
Genetics of SLE: evidence from mouse models
L Morel |
Nature Reviews Rheumatology | 2010 |
A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis
M Ban, JL McCauley, R Zuvich, A Baker, L Bergamaschi, M Cox, A Kemppinen, S D'Alfonso, FR Guerini, J Lechner-Scott, F Dudbridge, J Wason, NP Robertson, PL de Jager, DA Hafler, LF Barcellos, AJ Ivinson, D Sexton, JR Oksenberg, SL Hauser, MA Pericak-Vance, J Haines, A Compston, S Sawcer |
Genes and Immunity | 2010 |
Understanding Kidney Disease: Toward the Integration of Regulatory Networks Across Species
W Ju, FC 3rd |
Seminars in Nephrology | 2010 |
Mesangial pathology in glomerular disease: targets for therapeutic intervention
YM Scindia, US Deshmukh, H Bagavant |
Advanced Drug Delivery Reviews | 2010 |
Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus.
Yang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, Hirankarn N, Ying D, Pan HF, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Leung AM, Li XP, Avihingsanon Y, Wong CM, Lee TL, Ho MH, Lee PP, Chang YK, Li PH, Li RJ, Zhang L, Wong WH, Ng IO, Lau CS, Sham PC, Lau YL |
PLoS genetics | 2010 |
The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
Freedman BI, Edberg JC, Comeau ME, Murea M, Bowden DW, Divers J, Alarcón GS, Brown EE, McGwin G Jr, Kopp JB, Winkler CA, Nelson GW, Illei G, Petri M, Ramsey-Goldman R, Reveille JD, Vilá LM, Langefeld CD, Kimberly RP |
American Journal of Nephrology | 2010 |
Genetic contribution and associated pathophysiology in end-stage renal disease.
Agrawal S, Agarwal S, Naik S |
The Application of Clinical Genetics | 2010 |
Kallikreins and lupus nephritis
Claudio Ponticelli1 and Pier Luigi Meroni2 |
Journal of Clinical Investigation | 2009 |
SLE nephritis – learning from murine models
A Davidson, C Aranow |
Nature Reviews Rheumatology | 2009 |
Developments in the clinical understanding of lupus
MK Crow |
Arthritis Research & Therapy | 2009 |
Pathogenesis of kidney disease in systemic lupus erythematosus
H Bagavant, SM Fu |
Current Opinion in Rheumatology | 2009 |
Functional Roles of Human Kallikrein-related Peptidases*
G Sotiropoulou, G Pampalakis, EP Diamandis |
The Journal of biological chemistry | 2009 |